首页> 外文期刊>therapeutic drug monitoring >Comparison of a Fluorescence Polarization Immunoassay of Netilmicin in Plasma, Peritoneal Dialysate, and Urine with a High-Performance Liquid Chromatographic Method
【24h】

Comparison of a Fluorescence Polarization Immunoassay of Netilmicin in Plasma, Peritoneal Dialysate, and Urine with a High-Performance Liquid Chromatographic Method

机译:Comparison of a Fluorescence Polarization Immunoassay of Netilmicin in Plasma, Peritoneal Dialysate, and Urine with a High-Performance Liquid Chromatographic Method

获取原文
           

摘要

The quantitative analysis of netilmicin in plasma, peritoneal dialysate, and urine using the fluorescence polarization immunoassay (FPIA) of the Abbott TDx system is compared with the modified high-performance liquid chromatography (HPLC) method of Peng et al., which was chosen as a reference. Using the least square method, we found that the results of the FPIA (y) correlated well with those obtained with HPLC (x). The three regression equations for the plasma, peritoneal dialysate, and urine samples, respectively, werey= 0.71x+ 0.44 withr= 0.88 andn= 45;y= 0.94x+ 1.22 withr= 0.93 andn= 95; andy= 0.92x+ 0.70 withr= 0.93 andn= 61. The corresponding mean errors (FPIA-HPLC) with their 95 confidence intervals were -0.19 (-0.38 to -0.02), 0.69 (-0.42 to 1.81), and -0.13 (-1.13 to 0.87) micro;g/ml. According to results of the Wilcoxon matched-pairs signed-ranks test, these errors did not represent a significant bias. The FPIA is thus suitable for analyzing netilmicin in the three biological fluids studied except when dialysate is contaminated with Amuchina. In this case, HPLC should be used.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号